|
Dr. Pykett is President and Chief Operating Officer for Boston Life Sciences Inc. Previously Dr. Pykett was President CEO and Director for Cytomatrix LLC which he cofounded in 1996 and President of Cordlife Pte. Ltd. of Singapore which acquired Cytomatrix in 2003. Dr. Pykett graduated Phi Beta Kappa Summa Cum Laude from Amherst College holds a veterinary degree Phi Zeta Summa Cum Laude and doctorate in molecular biology from the University of Pennsylvania and received an M.B.A. degree Beta Gamma Sigma from Northeastern University. He completed post-doctoral fellowships at the University of Pennsylvania and Harvard University. In his research in academia Dr. Pykett focused on understanding the molecular basis of cancer. Dr. Pykett held an adjunct faculty position at the Harvard School of Public Health from 1997 to 2003. | 